March 21, 2019
Debt advisory, ESG
GCA Altium advises Waterland Private Equity on an acquisition financing for Rehacon
GCA Altium has advised Waterland Private Equity on an acquisition financing to support the creation of a buy-and-build platform in the German physiotherapeutic services market. Waterland is developing the company in partnership with the founder and shareholder of Rehacon, Michael Reeder. The shares are being sold by Reeder Invest GmbH, whose Managing Director Michael Reeder will retain a significant stake in Rehacon and will also continue to lead it.
Rehacon, based in Gelsenkirchen, operates more than 100 therapy centres throughout Germany, making it one of the largest providers on the market in continental Europe. With more than 600 employees, most of whom work directly with patients in the local therapy centres, the group creates an annual turnover of around EUR 36m.
GCA Altium structured a tailored financing package intended to further grow the business with a buy-and-build approach. Dr Carsten Rahlfs, Managing Partner at Waterland Private Equity, explained: “We want the firm to continue to grow by adding further therapy centres to its existing network and thereby strengthen its position in the market.”
Michael Reeder, added: “In Waterland, we have found the best partner to accelerate our growth. Their team has far-reaching experience in our market, an extremely strong network and shares our values.”
Dr Johannes Schmittat, Managing Director at GCA Altium, stated: “The financing structure will support the buy-and-build growth of Rehacon, by offering flexibility and funding for add-on acquisitions in the very interesting healthcare segment.“
The transaction closed last week and all parties agreed that no further details would be disclosed.